retatrutide triple agonist weight loss Severe Obesity Trial Shows 30% Retatrutide, a triple agonist, delivered

Family structure and unmet care needs among older adults with and without dementia in the United States

For many women, both perimenopause and menopause feels like the moment their body suddenly starts playing by different rules

Moser said more research is needed that utilizes objective taste and smell testing in addition to patient-reported outcomes, as well as assesses taste both before and after initiation of obesity treatment

2018 Aug 20;16(1):80

Check the expiration date before use and discard if expired

A novel approach to fat-fighting Based on this, researchers at the Tabriz University of Medical Sciences conducted a clinical trial to shed light on the promising combination of L-carnitine (a key player in glucose and lipid metabolism) and synbiotics that target gut microbiota dysbiosis as a formidable approach to tackle obesity and related cardio-metabolic complications